Glioblastoma.
Wirsching HG, Galanis E, Weller M.
Handb Clin Neurol. 2016;134:381-97. doi: 10.1016/B978-0-12-802997-8.00023-2.
Molecular targeted therapy of glioblastoma.
Le Rhun E, Preusser M, Roth P, Reardon DA, van den Bent M, Wen P, Reifenberger G, Weller M.
Cancer Treat Rev. 2019 Nov;80:101896. doi: 10.1016/j.ctrv.2019.101896. Epub 2019 Sep 11.
Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.
Gimple RC, Bhargava S, Dixit D, Rich JN.
Genes Dev. 2019 Jun 1;33(11-12):591-609. doi: 10.1101/gad.324301.119.
Glioblastoma and other malignant gliomas: a clinical review.
Omuro A, DeAngelis LM.
JAMA. 2013 Nov 6;310(17):1842-50. doi: 10.1001/jama.2013.280319.
A comprehensive profile of recurrent glioblastoma.
Campos B, Olsen LR, Urup T, Poulsen HS.
Oncogene. 2016 Nov 10;35(45):5819-5825. doi: 10.1038/onc.2016.85. Epub 2016 Apr 4.
Glioblastoma and brain connectivity: the need for a paradigm shift.
Salvalaggio A, Pini L, Bertoldo A, Corbetta M.
Lancet Neurol. 2024 Jul;23(7):740-748. doi: 10.1016/S1474-4422(24)00160-1.
The definition of primary and secondary glioblastoma.
Ohgaki H, Kleihues P.
Clin Cancer Res. 2013 Feb 15;19(4):764-72. doi: 10.1158/1078-0432.CCR-12-3002. Epub 2012 Dec 3.
[Glioblastoma in 2017].
Duffau H.
Rev Infirm. 2017 Feb;66(228):16-18. doi: 10.1016/j.revinf.2016.12.002.
Glioblastoma stem cell metabolism and immunity.
Hawly J, Murcar MG, Schcolnik-Cabrera A, Issa ME.
Cancer Metastasis Rev. 2024 Sep;43(3):1015-1035. doi: 10.1007/s10555-024-10183-w. Epub 2024 Mar 26.
Glioblastoma stem cells.
Tabatabai G, Weller M.
Cell Tissue Res. 2011 Mar;343(3):459-65. doi: 10.1007/s00441-010-1123-0. Epub 2011 Jan 21.
